GlassScriptPhysician profile
Adil Waheed
NPI 1265494819
$8,558.29
in general payments reported to CMS, 2019-2025
49 companies · $1,586 in 2025
The $1,586 reported for 2025 was more than what 80% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,964 · 2020: $995 · 2021: $1,077 · 2022: $716 · 2023: $656 · 2024: $1,564 · 2025: $1,586.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,062 · Travel and Lodging: $744.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,061.77 |
| Travel and Lodging | $744.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $1,119.44 | 2024-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Novartis Pharmaceuticals Corporation | $774.32 | 2019-2025 | |
| Boston Scientific Corporation | $655.20 | 2019-2025 | Watchman, General - Balloon Catheters |
| Abbott Laboratories | $575.03 | 2019-2025 | Jeti, Freestyle Libre 3, Nc Trek Neo |
| Astrazeneca Pharmaceuticals LP | $547.19 | 2019-2024 | Farxiga |
| Pfizer INC. | $546.68 | 2019-2025 | |
| Amgen INC. | $521.91 | 2019-2025 | Repatha, Prolia, Evenity |
| Janssen Pharmaceuticals, INC | $366.18 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $349.36 | 2019-2025 | Camzyos, Eliquis |
| Stryker Corporation | $313.85 | 2025 | Venacore Thrombectomy Catheter, Artix Mt, Flowtriever |
| Lilly USA, LLC | $251.03 | 2023-2025 | Jardiance, Zepbound, Mounjaro |
| Biotronik INC. | $221.69 | 2019-2022 | |
| Actelion Pharmaceuticals US, INC. | $216.53 | 2019-2021 | |
| Siemens Medical Solutions USA, INC. | $206.75 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $164.34 | 2019-2025 | Lifevest |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $127.14 | 2020-2025 | Jardiance |
| Penumbra, INC. | $113.81 | 2022-2025 | Indigo System |
| Dexcom, INC. | $110.30 | 2023-2025 | Dexcom G6 Transmitter |
| Novo Nordisk INC | $104.20 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
| Sanofi-Aventis U.S. LLC | $98.25 | 2019-2020 | |
| Medtronic, INC. | $96.79 | 2022-2025 | Minimed 780g, Venaseal |
| Cook Medical LLC | $90.43 | 2020-2025 | Cook |
| Akcea Therapeutics, INC. | $85.53 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $76.47 | 2019 | |
| Amarin Pharma, INC. | $72.33 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $70.60 | 2021-2025 | |
| Acella Pharmaceuticals, LLC | $68.08 | 2024-2025 | NP Thyroid 60 |
| Abiomed | $67.38 | 2024 | Impella |
| Cvrx, INC. | $62.66 | 2023 | Barostim Neo System |
| Esperion Therapeutics, INC. | $54.28 | 2020-2021 | |
| Teleflex LLC | $41.36 | 2023 | Supercross |
| Becton, Dickinson and Company | $38.50 | 2023 | Venovo |
| Terumo Medical Corporation | $36.24 | 2025 | Navicross |
| Astellas Pharma US INC | $31.19 | 2019-2022 | |
| Sequel Med Tech, LLC | $29.73 | 2025 | Twiist |
| Abbvie INC. | $27.25 | 2025 | |
| Neurocrine Biosciences, INC. | $26.56 | 2025 | |
| Amryt Pharma Holdings LTD | $21.83 | 2021 | |
| Ibsa Pharma INC. | $19.95 | 2023 | Tirosint, Licart |
| Chiesi USA, INC. | $19.76 | 2022 | |
| Corcept Therapeutics | $19.72 | 2022 | |
| Irhythm Technologies, INC. | $18.79 | 2022 | |
| Alexion Pharmaceuticals, INC. | $17.95 | 2025 | Strensiq |
| United Therapeutics Corporation | $16.49 | 2019-2021 | |
| Shockwave Medical, INC | $15.78 | 2023 | Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary |
| Cardiva Medical, INC. | $15.40 | 2023 | Cardiva Vascade 6/7f Vcs |
| Ascendis Pharma Endocrinology INC | $14.18 | 2025 | Yorvipath |
| Lundbeck LLC | $13.08 | 2019 | |
| Beta Bionics, INC. | $6.78 | 2024 | Ilet Bionic Pancreas |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adil Waheed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.